Multiomic profiling of cardiometabolic diseases (Illumina)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract, titled Multiomic profiling of cardiometabolic diseases (Illumina), is issued by the National Institutes of Health under solicitation number 75N98026Q00733 and is intended for the procurement of Illumina methylation and genotyping arrays to support genomic research at the Center for Research on Genomics and Global Health. The project will utilize three Infinium Methylation EPIC v2 kits and three Infinium Global Diversity Array-8 v1.0 kits, each designed for 96 samples, to enable comprehensive analysis of DNA methylation patterns and genetic variations in previously recruited participants. These arrays will be processed by the NHGRI Genomics Core, which is equipped with Illumina iScan and Autoloader systems along with a Tecan Liquid Handling Robot to ensure high-throughput, automated sample processing. The work is scoped as a one-time use initiative with all genotyping and methylation analyses required to be completed within one year of contract execution. The contract is a presolicitation with a response deadline of July 13, 2026, and requires no set-aside, falling under NAICS code 541714 for research and development in the physical, engineering, and life sciences. The performing organization is located in Bethesda, Maryland, with John Burton as the primary point of contact.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Requirements:
Purpose and Objectives:
This order is for methylation and genotyping arrays produced and manufactured by Illumina. The methylation beadchips are designed specifically for studying methylation changes across the genome while the genotyping arrays are designed for studying genetic variation across the genome. The Center for Research on Genomics and Global Health will use methylation beadchips and genotyping arrays to study gene methylation, genetic variations, and methylation quantitative traits in previously recruited participants. The methylation and genotypes will be generated by the NHGRI Genomics Core, which has the necessary equipment and expertise for efficient processing of Illumina SNP beadchips. The Core has an Illumina iScan, Illumina Autoloader, and a Tecan Liquid Handling Robot for automated processing of samples.
Period of Performance:
This is a one-time-use product, and the genotyping is expected to be completed within 1-year.
Contractor Requirements:
- The vendor shall provide:
- (3) Infinium Methylation EPIC v2 kits (96-sample kits)
- (3) Infinium Global Diversity Array -8 v1.0 Kit (96 samples)
